These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21794175)

  • 1. Pilot study on developing a decision support tool for guiding re-administration of chemotherapeutic agent after a serious adverse drug reaction.
    Loke PY; Chew L; Yap CW
    BMC Cancer; 2011 Jul; 11():319. PubMed ID: 21794175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical decision support tool to predict survival in cancer patients beyond 120 days after palliative chemotherapy.
    Ng T; Chew L; Yap CW
    J Palliat Med; 2012 Aug; 15(8):863-9. PubMed ID: 22690950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system.
    Koh Y; Yap CW; Li SC
    Int J Med Inform; 2008 Jun; 77(6):421-30. PubMed ID: 17921048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development and evaluation of a computerized decision aid for the treatment of psychotic disorders.
    Tasma M; Roebroek LO; Liemburg EJ; Knegtering H; Delespaul PA; Boonstra A; Swart M; Castelein S
    BMC Psychiatry; 2018 Jun; 18(1):163. PubMed ID: 29859050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can a Bayesian Belief Network Be Used to Estimate 1-year Survival in Patients With Bone Sarcomas?
    Nandra R; Parry M; Forsberg J; Grimer R
    Clin Orthop Relat Res; 2017 Jun; 475(6):1681-1689. PubMed ID: 28397168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the diagnosis of adverse drug reactions.
    Naranjo CA; Shear NH; Lanctôt KL
    J Clin Pharmacol; 1992 Oct; 32(10):897-904. PubMed ID: 1447396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II hypersensitivity reactions after oxaliplatin rechallenge can be life threatening.
    Vyskocil J; Tucek S; Kiss I; Fedorova L; Nevrlka J; Zdrazilova-Dubska L
    Int Immunopharmacol; 2019 Sep; 74():105728. PubMed ID: 31288153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individualized versus standardized risk assessment in patients at high risk for adverse drug reactions (IDrug) - study protocol for a pragmatic randomized controlled trial.
    Stingl JC; Kaumanns KL; Claus K; Lehmann ML; Kastenmüller K; Bleckwenn M; Hartmann G; Steffens M; Wirtz D; Leuchs AK; Benda N; Meier F; Schöffski O; Holdenrieder S; Coch C; Weckbecker K
    BMC Fam Pract; 2016 Apr; 17():49. PubMed ID: 27112273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision support tool for early differential diagnosis of acute lung injury and cardiogenic pulmonary edema in medical critically ill patients.
    Schmickl CN; Shahjehan K; Li G; Dhokarh R; Kashyap R; Janish C; Alsara A; Jaffe AS; Hubmayr RD; Gajic O
    Chest; 2012 Jan; 141(1):43-50. PubMed ID: 22030803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
    Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
    Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the impact of a decision support algorithm to improve clinicians' chemotherapy-induced peripheral neuropathy assessment and management practices: a two-phase, longitudinal study.
    Knoerl R; Mazzola E; Hong F; Salehi E; McCleary N; Ligibel J; Reyes K; Berry DL
    BMC Cancer; 2021 Mar; 21(1):236. PubMed ID: 33676431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of medication-related clinical decision support over-rides in the intensive care unit.
    Wong A; Amato MG; Seger DL; Rehr C; Wright A; Slight SP; Beeler PE; Orav EJ; Bates DW
    BMJ Qual Saf; 2018 Sep; 27(9):718-724. PubMed ID: 29440481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Causality assessment of adverse drug reaction reports using an expert-defined Bayesian network.
    Rodrigues PP; Ferreira-Santos D; Silva A; Polónia J; Ribeiro-Vaz I
    Artif Intell Med; 2018 Sep; 91():12-22. PubMed ID: 30077492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an automated decision support tool optimizes clinicians' ability to interpret and appropriately respond to structured self-monitoring of blood glucose data.
    Rodbard HW; Schnell O; Unger J; Rees C; Amstutz L; Parkin CG; Jelsovsky Z; Wegmann N; Axel-Schweitzer M; Wagner RS
    Diabetes Care; 2012 Apr; 35(4):693-8. PubMed ID: 22344611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensive safety monitoring program of antineoplastic medicines: A pilot study in a Portuguese oncology hospital.
    Mendes D; Rigueiro G; Silva RS; Penedones A; Alves C; Sousa G; Batel-Marques F
    J Oncol Pharm Pract; 2020 Jan; 26(1):133-140. PubMed ID: 31117914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A web-based clinical decision tool to support treatment decision-making in psychiatry: a pilot focus group study with clinicians, patients and carers.
    Henshall C; Marzano L; Smith K; Attenburrow MJ; Puntis S; Zlodre J; Kelly K; Broome MR; Shaw S; Barrera A; Molodynski A; Reid A; Geddes JR; Cipriani A
    BMC Psychiatry; 2017 Jul; 17(1):265. PubMed ID: 28732477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensible knowledge model creation for cancer treatment decision making.
    Afzal M; Hussain M; Ali Khan W; Ali T; Lee S; Huh EN; Farooq Ahmad H; Jamshed A; Iqbal H; Irfan M; Abbas Hydari M
    Comput Biol Med; 2017 Mar; 82():119-129. PubMed ID: 28187294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different methods for causality assessment of adverse drug reactions.
    Behera SK; Das S; Xavier AS; Velupula S; Sandhiya S
    Int J Clin Pharm; 2018 Aug; 40(4):903-910. PubMed ID: 30051231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent estimates of recurrence and survival in colon cancer: clinical decision support system tool development for adjuvant therapy and oncological outcome assessment.
    Steele SR; Bilchik A; Johnson EK; Nissan A; Peoples GE; Eberhardt JS; Kalina P; Petersen B; Brücher B; Protic M; Avital I; Stojadinovic A
    Am Surg; 2014 May; 80(5):441-53. PubMed ID: 24887722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.